Alpha Tau Medical Investor Relations Material

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company. The company specializes in the research, development, and commercialization of its proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) technology. This innovative therapy is designed for the treatment of solid tumors, with the ability to deliver highly potent and localized alpha radiation, minimizing damage to surrounding healthy tissues. Alpha Tau is focused on addressing unmet needs in various cancer types, including skin, oral, pancreatic, and prostate cancers, among others. The company is headquartered in Jerusalem, Israel, and its shares are listed on the NASDAQ.